Sorry, you need to enable JavaScript to visit this website.

Dosing Guide | XARELTO® (rivaroxaban) HCP

Condition-specific dosing for XARELTO®

Dosing Guide

The Dosing Guide is a comprehensive resource that provides direction on how to properly dose XARELTO® based on the patient’s condition.

The Dosing Guide also covers bleed risk, switching patients to and from XARELTO®, temporary discontinuation, administration, pharmacological profile, and guideline recommendations.

For VTE prophylaxis in acutely ill medical patients at risk for thromboembolic complications who are not at high risk of bleeding.

CAD = coronary artery disease; CrCl = creatinine clearance; CV = cardiovascular; DVT = deep vein thrombosis; NVAF = nonvalvular atrial fibrillation; PAD = pulmonary artery disease; PE = pulmonary embolism; VTE = venous thromboembolism.